Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: This study examines the risk of recurrent stroke, myocardial infarction (MI), vascular death, or all-cause death after hospitalized stroke in South Carolina.
Methods: Patients with a primary diagnosis of stroke discharged from the year 2002 were identified from the state hospital discharge database. Kaplan-Meier estimates of recurrent stroke, MI, vascular death, all-cause death, and composite events were calculated at 1 month, 6 months, 1 year, 2 years, 3 years, and 4 years. Prognostic factors were assessed with multivariate Cox proportional hazard models.
Results: The search strategy identified 10,399 patients in 2002. The Kaplan-Meier estimate of cumulative risk at 1 month, 6 months, 1 year, 2 years, 3 years, and 4 years for recurrent stroke is 1.8%, 5.0%, 8.0%, 12.1%, 15.2%, and 18.1%; MI, 0.3%, 1.0%, 2.1%, 3.7%, 5.0%, and 6.2%; all-cause death, 14.6%, 20.6%, 24.5%, 30.9%, 36.2%, and 41.3%; vascular death, 11.4%, 14.8%, 17.1%, 20.7%, 23.8%, and 26.7%; and composite events of recurrent stroke, MI, or vascular death 13.6%, 19.5%, 24.7%, 31.6%, 36.8%, and 41.3%. The hazard ratio for composite events (recurrent stroke, MI, or death) increases with age (1.38, 1.35–1.41), is 1.12 (1.05–1.19) for African Americans compared to Caucasians, is 1.67 (1.57–1.77) for patients with a higher comorbidity index (≥2 vs <2), and is 1.34 (1.28–1.39) for patients with subarachnoid hemorrhage or intracerebral hemorrhage compared with ischemic stroke.
Conclusions: These findings suggest there is room for further improvement in secondary stroke prevention in South Carolina.
Glossary
- AA=
- African American;
- ICD-9=
- International Classification of Diseases, 9th revision;
- ICH=
- intracranial hemorrhage;
- KM=
- Kaplan-Meier;
- MI=
- myocardial infarction;
- NOMASS=
- Northern Manhattan Stroke Study;
- ORS=
- Office of Research and Statistics;
- PCSS=
- Perth Community Stroke Study;
- SAH=
- subarachnoid hemorrhage.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrenceLuciano A. Sposato, Joshua O. Cerasuolo, Lauren E. Cipriano et al.Neurology, February 14, 2018 -
Article
Effect of coexisting vascular disease on long-term risk of recurrent events after TIA or strokeMarion Boulanger, Linxin Li, Shane Lyons et al.Neurology, July 23, 2019 -
Articles
Recurrent stroke and cardiac risks after first ischemic strokeThe Northern Manhattan StudyM. S. Dhamoon, R. R. Sciacca, T. Rundek et al.Neurology, March 13, 2006 -
Article
Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatalityKaren C. Albright, Lei Huang, Justin Blackburn et al.Neurology, October 03, 2018